Node-negative T1-T2 anal cancer: Radiotherapy alone or concomitant chemoradiotherapy?

In the management of node negative T1-T2 anal cancer, LRC and CSS tend to be superior in patients treated by combined CRT, even though the difference was not significant. Randomized studies are warranted to assess definitively the role of combined treatment in early-stage anal carcinoma.